The Food and Drug Administration has quickly approved a drug to combat basal cell carcinoma. That’s a type of skin cancer that - until now, patients had no other treatment options. From Phoenix, KJZZ's Terry Ward reports.
For questions or comments about this website, please contact the KJZZ webmaster. For general comments or questions see the Contact KJZZ page for a listing of contacts by topic.Please note: Station policy mandates that listeners who win on-air giveaways on this station are not eligible to win again for 30 days.
Email regarding NPR's coverage, ethics, and funding can be sent to the NPR Ombudsman, who maintains an informative web page. For comments or concerns regarding NPR programs, listeners with a general inquiry may send an email to nprhelp@npr.org
